Related Experiment Video
Updated: Jun 17, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers
Valerie A Braz1, Leslie A Holladay, Mary D Barkley
1Department of Chemistry, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA.
Efavirenz (EFV), an HIV-1 treatment, binds effectively to all forms of HIV-1 reverse transcriptase (RT). This nonnucleoside reverse transcriptase inhibitor exhibits slow, tight-binding kinetics across monomers and dimers.
Area of Science:
- Biochemistry
- Virology
- Pharmacology
Background:
- Efavirenz (EFV) is a crucial nonnucleoside reverse transcriptase inhibitor (NNRTI) for treating HIV-1 infection.
- HIV-1 reverse transcriptase (RT) exists as a heterodimer (p66/p51) and can form homodimers or exist as monomers.
- Dimerization of RT and EFV binding are interdependent processes.
Purpose of the Study:
- To investigate the binding characteristics of EFV to different forms of HIV-1 RT.
- To elucidate the mechanism of EFV binding and its kinetics.
Main Methods:
- Equilibrium dialysis
- Tryptophan fluorescence spectroscopy
- Native gel electrophoresis
- Progress curve analysis
Main Results:
- EFV exhibits 1:1 binding stoichiometry with RT monomers and homodimers.
- Equilibrium dissociation constants (Kd) varied, with the tightest binding observed for the p51/p51 homodimer (7 nM) and the heterodimer (92 nM).
- Binding and unbinding kinetics were slow, indicating a direct binding mechanism with a conformational selection component.
Conclusions:
- EFV is a slow, tight-binding inhibitor that interacts with all forms of HIV-1 RT.
- The NNRTI binding site appears conserved across monomeric and dimeric RT structures.
- These findings contribute to understanding HIV-1 drug resistance and developing new therapeutics.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Size and Structure of Viral Genomes
Retroviruses
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors

